Chemical Properties of Methyl 1,1'-dimethyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate (CAS 13897-71-7)

Methyl 1,1'-dimethyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate

PDF Excel Molecule Calculator
InChI
InChI=1S/C22H26N2O4/c1-13-15-11-24-9-8-22(17-6-4-5-7-18(17)23(2)21(22)26)19(24)10-14(15)16(12-28-13)20(25)27-3/h4-7,12-15,19H,8-11H2,1-3H3
InChI Key
UTVSHFGLVLURNU-UHFFFAOYSA-N
Formula
C22H26N2O4
SMILES
COC(=O)C1=COC(C)C2CN3CCC4(C(=O)N(C)c5ccccc54)C3CC12
Molecular Weight1
382.45
CAS
13897-71-7
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -2.84 Crippen Calculated Property
logPoct/wat 2.087 Crippen Calculated Property
McVol 284.180 ml/mol McGowan Calculated Property
Inp [2942.00; 2942.00]   Show Hide
Inp 2942.00 NIST
Inp 2942.00 NIST

Similar Compounds

Nalmefene. Strychnine. 3-O,6-O,N-Triacetylnormorphine. Benzylmorphine. Nicocodine. Buprenorphine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine.

Find more compounds similar to Methyl 1,1'-dimethyl-2-oxo-1',4a',5',5a',7',8',10',10a'-octahydrospiro[indoline-3,6'-pyrano[3,4-f]indolizine]-4'-carboxylate.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.